Privat · Selskap · Aksjeselskap
Serca Pharmaceuticals AS
921 663 846 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
Aktivitetsiste 24 mnd
Ingen stillingsannonseaktivitet registrert
totaler registrert · annonser-over-tid-serie ikke ennå i Intelligo
Registerendringer
Field change · kapital{"antallAksjer": 895550, "belop": 895550.0, "innfortDato": "2024-01-08", "type": "Aksjekapital", "valuta": "NOK"} → {"antallAksjer": 1046131, "belop": 1046131.0, "innfortDato": "2026-07-21", "type": "Aksjekapital", "valuta": "NOK"}2026-07-23
Field change · vedtektsdato2023-11-27 → 2026-02-252026-07-23
Accounts filed · sisteInnsendteAarsregnskap2024 → 20252026-06-19
NAV + JobStream · company_hiring · Brreg · company_changes
Tidslinjealle kilder
field_change: kapital{"antallAksjer": 895550, "belop": 895550.0, "innfortDato": "2024-01-08", "type": "Aksjekapital", "valuta": "NOK"} -> {"antallAksjer": 104...Register · 2026-07-23
field_change: vedtektsdato2023-11-27 -> 2026-02-25Register · 2026-07-23
accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Register · 2026-06-19
Revisors konklusjonThe auditor concludes that the financial statements comply with statutory requirements and give a true and fair view. — oppfyller arsregn...Årsrapport · 2025-12-31
Presisering om vesentlig usikkerhet fortsatt driftThe audit report contains a material uncertainty related to going concern paragraph referring to note 10. — erbeskreveti10,at detforeligg...Årsrapport · 2025-12-31
Note 10 – usikkerhet fortsatt driftThe company itself states there is uncertainty about going concern, being in a development phase with limited operating revenue and depen...Årsrapport · 2025-12-31
Avhengig av ekstern finansieringOperations depend on external financing because the company is in a development phase with limited revenues. — Selskapet er i en utviklin...Årsrapport · 2025-12-31
Fortsatt drift lagt til grunnThe accounts are nevertheless prepared on a going concern basis. — Arsregnskapeteravlagtunderforutsetningomfortsattdrift.Årsrapport · 2025-12-31
Kapitalforhøyelse etter balansedagenA capital increase with total contributions of NOK 16.9 million was resolved in a board meeting on 18 February 2026, after the balance sh...Årsrapport · 2025-12-31
Offentlig tilskudd utløst av kapitalutvidelsenThe capital increase triggers a public grant of NOK 16 million, securing full financing of phase 1. — offentlig tilskudd pa NoK 16 millio...Årsrapport · 2025-12-31
Aksjekapital og egenkapitalShare capital is NOK 895 550 with share premium NOK 19 924 852 and total equity NOK 27 895 940 at 31.12.2025. — Egenkapital 31.12.2025 8...Årsrapport · 2025-12-31
EierstrukturSarsia Seed Fond II AS holds 40.45 % and Inven2 AS 26.13 % of the shares. — INVEN2 AS SARSIASEEDFONDIIAS 362 247 234 032 26,13 Ordina...Årsrapport · 2025-12-31
Ytelser til ledende personerNo salary or other remuneration was paid to senior personnel. — Det erikkegittlonn,annen godtgjorelsemv.til ledendepersoner.Årsrapport · 2025-12-31
Lån og sikkerhetsstillelseNo loans or security have been granted to members of the governing bodies. — Det erikkegitt lanellersikkerhetsstillelsetil medlemmer avst...Årsrapport · 2025-12-31
Aktiverte utviklingskostnaderDevelopment costs for a new drug for treatment of heart infarction are capitalised and will be amortised from completion. — Selskapet har...Årsrapport · 2025-12-31
Ingen nedskrivningThe board finds no indication of impairment, so the capitalised development costs were not written down at 31.12.2025. — nedskrivning avd...Årsrapport · 2025-12-31
Antall årsverkThe company reports zero man-years in the financial year. — Antall arsverk i regnskapsaretÅrsrapport · 2025-12-31
Driftsinntekt fra ForskningsrådetAll 2025 operating income is IPN support of NOK 2 962 524 recognised from the Research Council of Norway. — For prosjektaret 2025 er det ...Årsrapport · 2025-12-31
SkatteFUNN-prosjektThe company has an industrial research project approved under the SkatteFUNN scheme. — Forskningsrad et industrielt forskningsprosjektiSk...Årsrapport · 2025-12-31
Revisor og signeringThe audit report is signed in Oslo on 12 May 2026 by state authorised auditor Knut Henrik Hammer-Holt of Unic Revisjon AS. — UnicRevisjon...Årsrapport · 2025-12-31
Auditor's clean opinionPwC concludes that the financial statements comply with law and give a true and fair view of the company's position at 31 December 2023. ...Årsrapport · 2023-12-31
Auditor identityThe audit report is signed by Hans-Christian Berger, state authorised auditor, of PricewaterhouseCoopers AS. — Hans-Christian Berger Sta...Årsrapport · 2023-12-31
Going concern uncertainty (note 8)Note 8 states that there is uncertainty related to going concern. — Deterknyttetusikkerhettilfortsattdrift.Årsrapport · 2023-12-31
Going concern - form answerThe Brreg form answer confirms uncertainty about going concern is present (Ja). — Er det usikkerhet om fortsatt drift?:JaÅrsrapport · 2023-12-31
Dependence on new financingThe company depends on additional liquidity, and management, board and main owners will work to secure further financing for 2024-2025. —...Årsrapport · 2023-12-31
No remuneration to managementNo salary or other remuneration was paid to leading personnel. — Deterikkegittlonn,annengodtgjorelsemv.tilledendepersoner.Årsrapport · 2023-12-31
CEO consultancy fees (related party)The CEO delivers consulting services to the company and invoiced NOK 451 650 excl. VAT for work performed in 2023. — Selskapets daglig le...Årsrapport · 2023-12-31
OwnershipSarsia Seed Fond II AS is the largest shareholder with 309 615 shares, 43.15%. — SARSIASEEDFONDIIAS Aksjonaerer Antall aksjer 309615 ...Årsrapport · 2023-12-31
Share capitalTotal number of shares is 717 496, representing 100% of capital. — Totalt antall aksjer 717496 100Årsrapport · 2023-12-31
Equity injection registered lateShare premium was injected in 2023 but only registered/journalised in 2024. — Detblei2023skutt innoverkursiselskapet,somblejournalforti2024.Årsrapport · 2023-12-31
Skiwo · company_events
Stillingsannonser pĂĄ NAV Arbeidsplassen12 MND
Ingen stillingsannonser registrert de siste 12 mĂĄnedene.
NAV Arbeidsplassen · company_job_ad_months
PlasseringOslo
Oslo
kun kommune · gateadresse + koordinater ikke ennå i Intelligo
Brreg · registrert kommune